Cumberland Pharmaceuticals Ownership | Who Owns Cumberland Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Cumberland Pharmaceuticals Ownership Summary


Cumberland Pharmaceuticals is owned by 6.02% institutional investors, 41.60% insiders, and 52.38% retail investors. Millennium management is the largest institutional shareholder, holding 5.42% of CPIX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.01% of its assets in Cumberland Pharmaceuticals shares.

CPIX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCumberland Pharmaceuticals6.02%41.60%52.38%
SectorHealthcare Stocks 35.34%11.88%52.77%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.67%13.90%65.43%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Millennium management809.90K5.42%$3.43M
Ikarian capital553.15K3.70%$1.80M
Renaissance470.70K3.15%$1.53M
Vanguard group411.79K2.75%$1.64M
Dimensional fund advisors lp276.36K1.85%$898.17K
Perceptive advisors196.98K1.32%$640.18K
Bridgeway capital management163.47K1.09%$531.27K
Boothbay fund management127.69K0.85%$415.01K
Blackrock110.56K0.78%$169.16K
Geode capital management114.29K0.76%$371.50K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ikarian capital553.15K0.15%$1.80M
Perceptive advisors196.98K0.01%$640.18K
Bridgeway capital management163.47K0.01%$531.27K
J. goldman & co lp81.04K0.01%$263.38K
Boothbay fund management127.69K0.01%$415.01K
Renaissance470.70K0.00%$1.53M
Millennium management809.90K0.00%$3.43M
Xtx topco24.01K0.00%$78.02K
Marex group36.42K0.00%$118.38K
Cresset asset management19.48K0.00%$63.29K

Top Buyers

HolderShares% AssetsChange
Millennium management809.90K0.00%809.90K
Vanguard fiduciary trust45.62K-45.62K
Marex group36.42K0.00%36.42K
Xtx topco24.01K0.00%24.01K
Arrowstreet capital, limited partnership20.25K-20.25K

Top Sellers

HolderShares% AssetsChange
Berkshire asset management llc/pa---153.81K
Adage capital partners gp---150.00K
Perceptive advisors196.98K0.01%-144.11K
Eam investors---71.78K
Walleye capital---70.42K

New Positions

HolderShares% AssetsChangeValue
Millennium management809.90K0.00%809.90K$3.43M
Vanguard fiduciary trust45.62K-45.62K$148.28K
Marex group36.42K0.00%36.42K$118.38K
Arrowstreet capital, limited partnership20.25K-20.25K$65.82K
Jane street group14.61K-14.61K$47.47K

Sold Out

HolderChange
Citigroup-4.00
Jpmorgan chase-19.00
Advisor group-200.00
Farther finance advisors-345.00
Innealta capital-948.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202614-54.84%900,136-69.56%61.54%7-30.00%3-70.00%
Dec 31, 202515-54.55%1,562,989-54.11%102.01%5-44.44%4-69.23%
Sep 30, 202532-3,406,301-7.49%223.76%9-40.00%1220.00%
Jun 30, 202532-17.95%3,682,268-13.97%243.00%15-21.05%1011.11%
Mar 31, 20253-85.71%1,549,897-15.86%106.04%3-25.00%--100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF280.82K2.01%-
Vanguard Total Stock Mkt Idx Inv274.81K1.84%-
Bridgeway Ultra-Small Company137.27K0.92%-
Vanguard Institutional Extnd Mkt Idx Tr86.94K0.58%-
IMC US Ultra Micro Cap79.25K0.53%-
DFA US Targeted Value I64.87K0.43%-
Fidelity Extended Market Index52.48K0.35%4.67K
Dimensional US Small Cap ETF49.95K0.33%-
DFA US Micro Cap I47.77K0.32%-
Pleiades Small Cap Equity A39.62K0.28%39.62K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 27, 2025Young Caroline-Buy$20.64
Aug 26, 2025Young Caroline-Buy$20.34
Aug 29, 2025Young Caroline-Buy$20.70
Aug 28, 2025Young Caroline-Buy$20.82
Aug 25, 2025Young Caroline-Buy$19.92

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q1--
2024 Q3--
2024 Q2--
2024 Q1--

CPIX Ownership FAQ


Who Owns Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals shareholders are primarily institutional investors at 6.02%, followed by 41.60% insiders and 52.38% retail investors. The average institutional ownership in Cumberland Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.67%, which Cumberland Pharmaceuticals falls below.

Who owns the most shares of Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals’s largest shareholders are Millennium management (809.9K shares, 5.42%), Ikarian capital (553.15K shares, 3.70%), and Renaissance (470.7K shares, 3.15%). Together, they hold 12.27% of Cumberland Pharmaceuticals’s total shares outstanding.

Does Blackrock own Cumberland Pharmaceuticals?

Yes, BlackRock owns 0.78% of Cumberland Pharmaceuticals, totaling 110.56K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 169.16K$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ikarian capital is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.15% of its assets in 553.15K Cumberland Pharmaceuticals shares, valued at 1.8M$.

Who is the top mutual fund holder of Cumberland Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cumberland Pharmaceuticals shares, with 2.01% of its total shares outstanding invested in 280.82K Cumberland Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools